-
By Staff writer |
July 19, 2004
July 16, 2004 -- The Smith Barney Fundamental Value/A (SHFVX) began buying large pharmaceuticals companies late last year. At that time, their stocks were trading...
-
By Staff writer |
August 25, 2003
S&P Rank: 4 Stars Aug. 14, 2003 On the Cusp of a New Drug Boom Quick Take: Drug and biotech stocks suffered in 2002, hurt by poor earnings,...
-
By Staff writer |
January 31, 2003
S&P Rank: 4 Stars Good Prognoses for Drug Stocks
-
By Staff writer |
October 16, 2002
S&P Rank: Not Ranked Sweet Home Minnesota!